ARK Invest files for an ETF focused on brain-computer interfaces and surgical robotics
A preliminary SEC prospectus filed on November 6 describes an actively managed ARK fund that would invest in BCI and surgical robotics companies, including possibly private ones.
ARK Investment Management has filed a preliminary prospectus for an “ARK Brain Computer Interfaces & Surgical Robotics ETF”, one of 14 new thematic funds in a November 6 amendment to its ETF trust’s SEC registration. The filing defines BCI companies as those developing or commercializing devices that link the nervous system directly to an external device. The fund would put at least 80% of its assets into that theme and surgical robotics, mostly through total return swaps. It could also hold private and restricted securities. No ticker or fee is given, and the amendment is set to take effect 75 days after filing at the earliest.
The prospectus names no intended holdings, and most leading BCI developers are still private. A filing like this signals investor interest in the field, but the fund may change or never launch.
Learn more: Brain-computer interface